Thyrocare Technologies informs about outcome of board meeting

30 Apr 2022 Evaluate
Thyrocare Technologies has informed that the Board of Directors of the Company, at their meeting held yesterday, approved the Audited Financial Results (Stand-alone and Consolidated) for the Financial Year ended March 31, 2022 and have also decided to declare an interim dividend at the rate of Rs 15.00 per share (150% of the face value of Rs 10 each) for the financial year 2021-22. The Board has fixed, Thursday 12th May 2022 as the record date for the purpose of determining the entitlement of shareholders for the interim dividend. 

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

366.60 -2.85 (-0.77%)
12-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7574.30
Max Healthcare Inst 1020.30
Narayana Hrudayalay 1703.50
Aster DM Healthcare 685.35
Global Health 1102.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×